tiprankstipranks
Advertisement
Advertisement

HIND Stock Latest News

Vyome signs exclusive license agreement with Impetis
The FlyVyome signs exclusive license agreement with Impetis
16d ago
HIND
Vyome initiated with a Buy at Litchfield Hills
PremiumThe Fly
Vyome initiated with a Buy at Litchfield Hills
24d ago
HIND
Vyome Holdings Shareholders Tighten Capital Structure at Meeting
PremiumCompany Announcements
Vyome Holdings Shareholders Tighten Capital Structure at Meeting
28d ago
8K
HIND
Vyome Therapeutics: Undervalued Buy on De-Risked VT-1953 Program and Pivotal Phase 3 Catalyst in a >$2B Orphan Market
PremiumRatings
Vyome Therapeutics: Undervalued Buy on De-Risked VT-1953 Program and Pivotal Phase 3 Catalyst in a >$2B Orphan Market
1M ago
HIND
Vyome Holdings presents Phase 2 study results on VT-1953
PremiumThe Fly
Vyome Holdings presents Phase 2 study results on VT-1953
1M ago
HIND
Vyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
PremiumThe FlyVyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
2M ago
HIND
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
Premium
The Fly
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
2M ago
HIND
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
Premium
Company Announcements
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
3M ago
8K
HIND
Vyome Holdings publishes preclinical VT-1908 data
PremiumThe Fly
Vyome Holdings publishes preclinical VT-1908 data
3M ago
HIND
Vyome Reports Positive Phase 2 Data for VT-1953 Gel
PremiumCompany Announcements
Vyome Reports Positive Phase 2 Data for VT-1953 Gel
3M ago
8K
HIND
Vyome Holdings funds budget for VT-1953 study
PremiumThe Fly
Vyome Holdings funds budget for VT-1953 study
4M ago
HIND
Vyome Holdings Highlights VT-1953 Market Potential Analysis
PremiumCompany Announcements
Vyome Holdings Highlights VT-1953 Market Potential Analysis
4M ago
8K
HIND
Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition
PremiumCompany AnnouncementsVyome’s LiveChain Signs LOI for Humanyze Note Acquisition
5M ago
8K
HIND
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
Premium
Ratings
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
6M ago
HIND
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
Premium
The Fly
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
6M ago
HIND
Vyome Holdings Inc. Reports Post-Merger Financials
PremiumCompany Announcements
Vyome Holdings Inc. Reports Post-Merger Financials
6M ago
HIND
Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential
PremiumRatings
Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential
6M ago
HIND
Vyome Holdings files to sell 610K shares of common stock for holders
PremiumThe Fly
Vyome Holdings files to sell 610K shares of common stock for holders
7M ago
HIND
Vyome Holdings Elects Directors at Annual Meeting
PremiumCompany Announcements
Vyome Holdings Elects Directors at Annual Meeting
7M ago
8K
HIND
Vyome Holdings Acquires AI Startup Oculo, Inc.
PremiumCompany AnnouncementsVyome Holdings Acquires AI Startup Oculo, Inc.
8M ago
8K
HIND
Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
Premium
The Fly
Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
8M ago
HIND
Vyome Holdings upgraded to Buy from Hold at Maxim
Premium
The Fly
Vyome Holdings upgraded to Buy from Hold at Maxim
8M ago
HIND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >